5Shaw JE,Sicree RA,Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030[J].{H}Diabetes Research and Clinical Practice,2010,(01):4-14.
6Xu Y,Wang L,He J. 2010 China Noncommunicable Disease Surveillance Group.Prevalence and control of diabetes in Chinese adults[J].{H}JAMA:the Journal of the American Medical Association,2013,(09):948-959.
7Sun YM,Su Y,Li J. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy[J].{H}Biochemical and Biophysical Research Communications,2013,(04):359-361.
8de Boer IH,Rue TC,Cleary PA. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria:an analysis of the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort[J].{H}Archives of Internal Medicine,2011,(05):412-420.
9DCCT/EDIC Research Group,de Boer IH,Sun W. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes n[J].{H}New England Journal of Medicine,2011,(25):2366-2376.
10Holman RR,Paul SK,Bethel MA. 10-year follow-up of intensive glucose control in type 2 diabetes[J].{H}New England Journal of Medicine,2008,(15):1577-1589.
